[18F]-DCFPyL Positron Emission Tomography/Magnetic Resonance Imaging for Localization of Dominant Intraprostatic Foci: First Experience.
Sign Up to like & getrecommendations! Published in 2018 at "European urology focus"
DOI: 10.1016/j.euf.2016.10.002
Abstract: An ongoing prospective study is acquiring preoperative imaging data for men with prostate cancer (PCa) using the molecular imaging agent [18F]-DCFPyL targeted against prostate-specific membrane antigen (PSMA). To date, six men (of a planned accrual… read more here.
Keywords: prostate; 18f dcfpyl; pathology; positron emission ... See more keywords
Role of 18F-DCFPyL PET/CT in patients with suspected prostate cancer.
Sign Up to like & getrecommendations! Published in 2022 at "Hellenic journal of nuclear medicine"
DOI: 10.1967/s002449912431
Abstract: OBJECTIVE Fluorine-18-2-(3-{1-carboxy-5-[(6-18F-flfluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid (18F-DCFPyL), a novel positron emission tomography/computed tomography (PET/CT) radiotracer that binds to the prostate specific membrane antigen (PSMA), is increasingly used for biochemically recurrent prostate cancer diagnostics. However, the 18F-DCFPyL characteristics of… read more here.
Keywords: prostate cancer; dcfpyl; dcfpyl pet; 18f dcfpyl ... See more keywords
Salivary excretion of systemically injected [18F]DCFPyL in prostate cancer patients undergoing PSMA scans
Sign Up to like & getrecommendations! Published in 2024 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2024.1367962
Abstract: Introduction Prostate-specific membrane antigen (PSMA) is present in high amounts in salivary glands, but it is unclear whether labeled binders of PSMA are excreted in the saliva. Methods Ten patients with prostate cancer underwent whole-body… read more here.
Keywords: 18f dcfpyl; prostate cancer; dcfpyl; salivary excretion ... See more keywords